Dr Malcolm Gillies
UNSW SydneyLearn more opens in a new window
Project Incubator Program
Australia has looked on with concern at the widespread harm from prescription opioid painkillers in the US. Until recently, Australian use of prescription opioids such as oxycodone was increasing, and with it worries about addiction, overdose and other problems. Many people are prescribed these medicines after a visit to hospital and research in Australia and elsewhere has suggested that these individuals can go on to long-term and potentially problematic use. This project aims to generate robust and actionable information about the prevalence and natural history of prescription opioid use initiated during or soon after a hospital visit in Australia, focusing on persistent or long-term use and its harms.
Jun - Dec 2023
What is the prevalence and natural history of opioid use initiated during hospital stay or post-discharge in New South Wales, particularly the prevalence of persistent opioid use?
We will use population-based, linked administrative health data from the Medicines Intelligence Data Platform, comprising Pharmaceutical Benefit Scheme (PBS), Medicare Benefit Schedule (MBS), National Death Index (NDI)/Cause-of-death Unit Record File (CODURF), NSW Admitted Patient Data Collection (APDC), NSW Emergency Department Data Collection (EDDC), and NSW Clinical Cancer Registry (CCR) for all adult residents of NSW from 2002-2021.
Evidence from this study can help inform the type of interventions and their timing to reduce the risks associated with opioids initiated during hospital stay or at discharge
This section will be updated throughout the project. Please return in the future to see the impact from this project.